MUC-1-KLH vaccine, QS-21 adjuvanted (Memorial Sloan-Kettering Cancer Center)
N/A
Report date: 2024/12/11 10:05:09
Base Information
Drug NameMUC-1-KLH vaccine, QS-21 adjuvanted (Memorial Sloan-Kettering Cancer Center)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A